Immune response of sows vaccinated with attenuated transmissible gastroenteritis virus (TGEV) and recombinant TGEV spike protein vaccines and protection of their suckling pigs against virulent TGEV challenge exposure

Seongkuk Park From the Food Animal Health Research Program, Department of Veterinary Preventive Medicine, Ohio Agricultural Research and Development Center (OARDC), The Ohio State University, Wooster, OH 44691.

Search for other papers by Seongkuk Park in
Current site
Google Scholar
PubMed
Close
 DVM, MVSc
,
Karol Sestak From the Food Animal Health Research Program, Department of Veterinary Preventive Medicine, Ohio Agricultural Research and Development Center (OARDC), The Ohio State University, Wooster, OH 44691.

Search for other papers by Karol Sestak in
Current site
Google Scholar
PubMed
Close
 DVM
,
Douglas C. Hodgins From the Food Animal Health Research Program, Department of Veterinary Preventive Medicine, Ohio Agricultural Research and Development Center (OARDC), The Ohio State University, Wooster, OH 44691.

Search for other papers by Douglas C. Hodgins in
Current site
Google Scholar
PubMed
Close
 DVM, PhD
,
David I. Shoup From the Food Animal Health Research Program, Department of Veterinary Preventive Medicine, Ohio Agricultural Research and Development Center (OARDC), The Ohio State University, Wooster, OH 44691.

Search for other papers by David I. Shoup in
Current site
Google Scholar
PubMed
Close
 DVM, PhD
,
Lucy A. Ward From the Food Animal Health Research Program, Department of Veterinary Preventive Medicine, Ohio Agricultural Research and Development Center (OARDC), The Ohio State University, Wooster, OH 44691.

Search for other papers by Lucy A. Ward in
Current site
Google Scholar
PubMed
Close
 DVM, PhD
,
Daral J. Jackwood From the Food Animal Health Research Program, Department of Veterinary Preventive Medicine, Ohio Agricultural Research and Development Center (OARDC), The Ohio State University, Wooster, OH 44691.

Search for other papers by Daral J. Jackwood in
Current site
Google Scholar
PubMed
Close
 MS, PhD
, and
Linda J. Saif From the Food Animal Health Research Program, Department of Veterinary Preventive Medicine, Ohio Agricultural Research and Development Center (OARDC), The Ohio State University, Wooster, OH 44691.

Search for other papers by Linda J. Saif in
Current site
Google Scholar
PubMed
Close
 PhD

Click on author name to view affiliation information

Abstract

Objective

To compare recombinant transmissible gastroenteritis virus (TGEV) spike protein, (SP) R2-2, with attenuated live virus (ALV) vaccine in sows during late pregnancy.

Animals

13 TGEV-seronegative sows and their pigs.

Procedure

At prepartum weeks (PPW) 6 and 4, sows of groups 1 and 2 received ALV via the oral/intranasal (O/IN) route. At PPW 2, group-1 sows received ALV IM and group-2 sows received SPR2-2 IM. Group-3 sows received SPR2-2 IM at PPW 4 and ALV O/IN at PPW 2. Sows of group 4 (negative controls) were inoculated O/IN with mock-infected ST cell fluids at PPW 6 and 4 and IM with Sf9 cell lysates at PPW2 (n = 2), or IM with Sf9 cell lysates at PPW4 and O/IN with mock-infected ST cell fluids at PPW2 (2). Serum, colostrum, and milk samples were tested for antibody to TGEV, and a lymphoproliferative (LP) assay was done on blood mononuclear cells. Suckling pigs were challenge exposed with virulent TGEV.

Results

Sows of groups 1 and 2 had higher IgG and significantly higher antibody titers in colostrum; their pigs had significantly higher serum antibody titer. At challenge exposure of their pigs, LP responses of group-2 sows were significantly higher than those of sows in the other 3 groups. Mean pig mortality ranged from 43 (group 2) to 92% (group 4). Significant negative correlations were observed among litter mortality and sow LP response, colostral titer, and pig serum titer at time of challenge exposure.

Conclusions

In sows vaccinated twice with attenuated live TGEV, the recombinant SPR2-2 administered IM may be comparable to ALV administered IM as a booster. Vaccination failed to provide complete protection to suckling pigs after challenge exposure. (Am J Vet Res 1998;59:1002–1008)

Abstract

Objective

To compare recombinant transmissible gastroenteritis virus (TGEV) spike protein, (SP) R2-2, with attenuated live virus (ALV) vaccine in sows during late pregnancy.

Animals

13 TGEV-seronegative sows and their pigs.

Procedure

At prepartum weeks (PPW) 6 and 4, sows of groups 1 and 2 received ALV via the oral/intranasal (O/IN) route. At PPW 2, group-1 sows received ALV IM and group-2 sows received SPR2-2 IM. Group-3 sows received SPR2-2 IM at PPW 4 and ALV O/IN at PPW 2. Sows of group 4 (negative controls) were inoculated O/IN with mock-infected ST cell fluids at PPW 6 and 4 and IM with Sf9 cell lysates at PPW2 (n = 2), or IM with Sf9 cell lysates at PPW4 and O/IN with mock-infected ST cell fluids at PPW2 (2). Serum, colostrum, and milk samples were tested for antibody to TGEV, and a lymphoproliferative (LP) assay was done on blood mononuclear cells. Suckling pigs were challenge exposed with virulent TGEV.

Results

Sows of groups 1 and 2 had higher IgG and significantly higher antibody titers in colostrum; their pigs had significantly higher serum antibody titer. At challenge exposure of their pigs, LP responses of group-2 sows were significantly higher than those of sows in the other 3 groups. Mean pig mortality ranged from 43 (group 2) to 92% (group 4). Significant negative correlations were observed among litter mortality and sow LP response, colostral titer, and pig serum titer at time of challenge exposure.

Conclusions

In sows vaccinated twice with attenuated live TGEV, the recombinant SPR2-2 administered IM may be comparable to ALV administered IM as a booster. Vaccination failed to provide complete protection to suckling pigs after challenge exposure. (Am J Vet Res 1998;59:1002–1008)

All Time Past Year Past 30 Days
Abstract Views 0 0 0
Full Text Views 175 175 38
PDF Downloads 28 28 3
Advertisement